Qualitative interviews to understand health care providers’ experiences of prescribing licensed peanut oral immunotherapy

por Anagnostou, Aikaterini, Lawrence, Claire, Tilles, Stephen A., Laubach, Susan, Donelson, Sarah M., Yassine, Mohamed, Nowak-Wegrzyn, Anna
Publicado 2022

Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice

por Portnoy, Jay, Ciaccio, Christina E., Beausoleil, Janet, Du Toit, George, Fineman, Stanley, Tilles, Stephen A., Zhang, June, Lawrence, Claire, Yassine, Mohamed, Mustafa, S Shahzad
Publicado 2022

Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States

por Blaiss, Michael S, Meadows, J Allen, Yu, Shengsheng, Robison, Dan R, Hass, Steve L, Norrett, Kevin E, Guerin, Annie, Latremouille-Viau, Dominick, Tilles, Stephen A
Publicado 2021

Manufacturing processes of peanut (Arachis hypogaea) allergen powder-dnfp

por Leonard, Stephanie A., Ogawa, Yasushi, Jedrzejewski, Paul T., Maleki, Soheila J., Chapman, Martin D., Tilles, Stephen A., Du Toit, George, Mustafa, S. Shahzad, Vickery, Brian P.
Publicado 2022

The importance of allergic disease in public health: an iCAALL statement

por Sánchez-Borges, Mario, Martin, Bryan L., Muraro, Antonella M., Wood, Robert A., Agache, Ioana O., Ansotegui, Ignacio J., Casale, Thomas B., Fleisher, Thomas A., Hellings, Peter W., Papadopoulos, Nikolaos G., Peden, David B., Sublett, James L., Tilles, Stephen A., Rosenwasser, Lanny
Publicado 2018